Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Last Updated
In the Matter of DaVita, Inc., a corporation, and Total Renal Care, Inc., a corporation.
FTC Matter/File Number
2110013

Case Summary

The Federal Trade Commission issued a proposed order imposing strict limits on future mergers by DaVita, Inc., a dialysis service provider with a history of fueling consolidation in life-saving health industries. The complaint alleged that DaVita’s proposed acquisition of the University of Utah Health’s dialysis clinics would reduce competition in vital outpatient dialysis services in the Provo, Utah market. Under the proposed order, DaVita is required to divest three Provo-area dialysis clinics to Sanderling Renal Services, Inc. and is prohibited from entering into or enforcing non-compete agreements and other employee restrictions.